Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?

Creator

La Caze, Adam

Bibliographic Citation

Pharmacoeconomics 2005; 23(5): 445-447

Permanent Link

Find Full Text at Georgetown University Library
http://hdl.handle.net/10822/506063

Date

2005

Subject

Health; Public Health; Pharmacogenomics; Allocation of Health Care Resources; Drugs and Drug Industry; Genome Mapping; Economics of Health Care;

Collections

GenEthx: Genetics and Ethics Database

Metadata

Show full item record